In light of a recent report suggesting that upregulation of PF-4 may play a crucial role in the early stages of several cancers [19], we propose here that upregulation of this peptide in our study was crucial in preventing angiogenesis at the tumor site in early prostate cancer. The gene discussed is PF4; the disease is prostate cancer.